Jeffrey S. Heier

OCUL

Jeffrey S. Heier serves as officer: Chief Scientific Officer at Ocular Therapeutix, Inc. (OCUL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$45.8K

Total Sells

7 trades

$289.2K

Net Position

Net Seller

$243.5K

Companies Traded

OCUL

Active Period

May 2022 – Feb 2026

8 total trades

Most Recent

Sell OCUL

Feb 25, 2026 · $25.3K

Jeffrey S. Heier's Insider Trading at Ocular Therapeutix, Inc. (OCUL)

Buys

1 · $45.8K

Sells

7 · $289.2K

Total Shares Bought

15,000

Total Shares Sold

29,124

OCUL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 25, 2026	Sell	3,057	$8.28	$25.3K	323,368
Nov 26, 2025	Sell	3,469	$12.04	$41.8K	245,940
Oct 6, 2025	Sell	10,502	$11.04	$115.9K	249,409
Aug 27, 2025	Sell	3,063	$12.04	$36.9K	259,911
May 27, 2025	Sell	3,024	$7.18	$21.7K	262,974
Feb 26, 2025	Sell	3,061	$6.87	$21.0K	265,998
Nov 27, 2024	Sell	2,948	$9.01	$26.6K	269,059
May 16, 2022	Buy	15,000	$3.05	$45.8K	39,000